-
Keefe, Bruyette & Woods Reiterates Mid-America Apartment Communities Outperform
Tuesday, February 7, 2012 - 4:35pmKeefe, Bruyette & Woods reiterated its Mid-America Apartment Communities (NYSE: MAA) Outperform rating in a research report published today. Keefe, Bruyette & Woods has a $69 price target on the company. In the report, Keefe, Bruyette & Woods states, "MAA stacks up favorably versus...
Read More >> -
UPDATE: Jefferies Downgrades SL Green Realty, Upgrades Mid-America Apartment Communities
Tuesday, February 7, 2012 - 9:01amIn a research report published today, Jefferies gave bits of insight into the future of several different companies. Jefferies downgraded SL Green Realty Corp. (NYSE: SLG) from Buy to Hold, and upgraded Mid-America Apartment Companies Inc. (NYSE: MAA) from Hold to Buy. In the report, for example...
Read More >> -
Trius Earns $5 Million Milestone Payment From Bayer for Successful Completion of First Phase 3 Trial of Tedizolid
Monday, January 23, 2012 - 7:00amTrius Therapeutics, Inc. (Nasdaq: TSRX) announced today that it has earned a $5 million milestone payment from Bayer Healthcare for the achievement of all efficacy and safety objectives in the TR701-112 Phase 3 pivotal study which tested the oral dosage form of tedizolid phosphate versus the...
Read More >> -
Trius Reports Positive Results From First Phase 3 Trial of Tedizolid in Acute Bacterial Skin and Skin Structure Infections
Monday, December 19, 2011 - 7:01amTrius Therapeutics, Inc. (Nasdaq: TSRX) announced today that tedizolid phosphate met the primary objective of non-inferiority for the efficacy outcome of early clinical response versus the comparator linezolid (Zyvox®) in patients with acute bacterial skin and skin structure infections (ABSSSI)....
Read More >> -
UPDATE: FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™
Tuesday, December 13, 2011 - 6:55amAlexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend that ADASUVE™ (Staccato® loxapine) be approved for use as a single dose in 24 hours when used with the FDA recommended...
Read More >> -
MAA Announces Acquisitions
Monday, December 12, 2011 - 9:01amMAA (NYSE: MAA) announced today that it has completed the acquisitions of Palisades at Chenal Valley, a 248-unit apartment community located in Little Rock, Arkansas and The River's Walk at Celebrate Virginia, a 232-unit apartment community located in Fredericksburg, Virginia.
Read More >> -
MAA Appoints Thomas L. Grimes, Jr. Chief Operating Officer
Wednesday, December 7, 2011 - 4:00pmMAA (NYSE: MAA) announced today that Thomas L. Grimes, Jr. has been appointed Executive Vice-President and Chief Operating Officer. Mr. Grimes joined the company in 1994 shortly after MAA's initial public offering and has served as Executive Vice-President and Director of Property Management...
Read More >> -
Mid-America Apartment Communities Announces Quarterly Common Dividend Increase by 5.2%
Thursday, December 1, 2011 - 4:28pmMAA (NYSE: MAA) today announced that its board of directors voted to increase the quarterly common dividend by 5.2% to a quarterly payment of $0.66 per share, or $2.64 per share on an annual basis.
Read More >> -
Dynavax Confirms HEPLISAV Submission Strategies With U.S. FDA and EMA
Thursday, October 27, 2011 - 3:10pmDynavax Technologies Corporation (NASDAQ: DVAX) today said that the U.S. Food and Drug Administration had concurred with the company's plan to submit a Biologics License Application for HEPLISAV for persons over 40 years of age, followed by a supplemental BLA for licensure of a specific regimen for...
Read More >> -
MAA Announces Acquisition of Apartment Community
Wednesday, October 19, 2011 - 8:05amMAA (NYSE: MAA) announced today that it has completed the acquisition of Aventura at Indian Lake Village, a 300-unit apartment community located in the Nashville metropolitan statistical area.
Read More >>

















